Role of 20-HETE in Endothelial Dysfunction
20-HETE 在内皮功能障碍中的作用
基本信息
- 批准号:7137827
- 负责人:
- 金额:$ 32.73万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-09-01 至 2010-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
This is a proposal to investigate the function and regulation of 20-hydroxyeicosatetraenoic acid (20-
HETE) synthesis in the vasculature, more specifically, its participation in endothelium dysfunction in
models of increased vascular expression of cytochrome P450 (CYP) 4A. 20-HETE is a primary
eicosanoid in the microcirculation where it participates in the regulation of vascular tone. In rat renal
arteries, CYP4A expression and 20-HETE production increased with decreased arterial diameter.
CYP4A overexpression in small arteries and arterioles increased vascular reactivity and myogenic tone.
Recent studies and preliminary results suggest that the endothelium is a target for 20-HETE bioactions.
Smooth muscle-specific CYP4A1 expression via Ad-SM22-4A1 induces a marked CYP4A-dependent
and 20-HETE-mediated endothelial sprouting in renal arterial microvessels. In vitro, 20-HETE is a
potent angiogenic factor stimulating capillary-like tube formation of endothelial cells by a mechanism
that may include MAPK activation and induction of inflammatory and angiogenic proteins (IL-8 and
VEGF). In vivo, intravenous injection of Adv-CYP4A2 causes hypertension and renal arteries from
these rats display endothelial dysfunction, which can be reversed by inhibition of CYP4A activity.
Arteries from Adv-CYP4A2-transduced rats produce more 20-HETE and less NO; they also express
higher levels of inflammatory proteins (ICAM and VCAM). These findings raise the possibility that
vascular 20-HETE is an important determinant of endothelial dysfunction, a condition that is
characterized by decreased NO bioavailability and enhanced endothelial activation, and are the basis
for the proposal's hypothesis: Vascular overexpression of CYP4A fosters prohypertensive
mechanisms via increased production of 20-HETE in a manner that may include endothelial
dysfunction and activation. This hypothesis will be tested by 1) determining the relationship between
hypertension, endothelial dysfunction and activation, CYP4A expression and 20-HETE synthesis; 2)
determining whether the functional consequences of increased vascular expression of CYP4A is
associated with endothelial expression and synthesis of CYP4A and 20-HETE, respectively; and 3)
exploring mechanisms underlying 20-HETE mediated endothelial dysfunction and activation.
本研究旨在探讨20-羟基二十碳四烯酸(20-hydroxyyeicosatetraenoic acid,20-HA)在细胞内的功能和调控。
HETE)合成,更具体地说,它参与血管内皮功能障碍,
细胞色素P450(CYP 450)4A血管表达增加的模型。20-HETE是主要的
类花生酸在微循环中参与血管张力的调节。大鼠肾
随着动脉直径的减小,CYP 4A表达和20-HETE产生增加。
小动脉和小动脉中CYP 4A过表达增加血管反应性和肌原性张力。
最近的研究和初步结果表明,内皮细胞是20-HETE生物作用的靶点。
通过Ad-SM 22 - 4A 1的平滑肌特异性CYP 4A 1表达诱导显著的CYP 4A依赖性
和20-HETE介导的肾动脉微血管内皮发芽。在体外,20-HETE是一种
通过一种机制刺激内皮细胞的毛细血管样管形成的有效的血管生成因子
这可能包括MAPK激活和诱导炎症和血管生成蛋白(IL-8和
VEGF)。在体内,静脉注射Adv-CYP 4A 2可导致高血压和肾动脉阻塞。
这些大鼠表现出内皮功能障碍,其可以通过抑制CYP 4A活性来逆转。
来自Adv-CYP 4A 2转导大鼠的动脉产生更多的20-HETE和更少的NO;它们还表达
炎症蛋白(ICAM和VCAM)水平升高。这些发现提出了一种可能性,
血管20-HETE是内皮功能障碍的重要决定因素,内皮功能障碍是一种
其特征在于降低NO生物利用度和增强内皮活化,并且是基础。
该提案的假设:血管中CYP 4A的过度表达促进高血压
通过增加20-HETE产生的机制,可能包括内皮细胞
功能障碍和激活。该假设将通过以下方式进行检验:1)确定以下之间的关系
高血压、内皮功能障碍和激活、CYP 4A表达和20-HETE合成; 2)
确定CYP 4A血管表达增加的功能后果是否
分别与内皮细胞表达和CYP 4A和20-HETE合成相关;和3)
探索20-HETE介导的内皮功能障碍和活化的潜在机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michal Laniado Schwartzman其他文献
G6PD and CYP450 Enzyme Regulate Hematopoietic Stem Cell Biology: Implication to Pulmonary Artery Remodeling in Pulmonary Hypertension
G6PD 和 CYP450 酶调节造血干细胞生物学:对肺动脉高压肺动脉重塑的影响
- DOI:
- 发表时间:
2018 - 期刊:
- 影响因子:0
- 作者:
Ryota Hashimoto;Sachindra Raj Joshi;Houli Jiang;Jorge H. Capdevila;Michal Laniado Schwartzman;Sachin A. Gupte - 通讯作者:
Sachin A. Gupte
Cytochrome p450-eicosanoids: endothelial dysfunction and arterial hypertension
- DOI:
10.1016/j.biopha.2008.07.039 - 发表时间:
2008-10-01 - 期刊:
- 影响因子:
- 作者:
Michal Laniado Schwartzman;Jennifer Cheng - 通讯作者:
Jennifer Cheng
Michal Laniado Schwartzman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michal Laniado Schwartzman', 18)}}的其他基金
GPR75 in obesity-driven cardiovascular and metabolic complications
GPR75 在肥胖引起的心血管和代谢并发症中的作用
- 批准号:
10633523 - 财政年份:2023
- 资助金额:
$ 32.73万 - 项目类别:
FUNCTION AND REGULATION OF CYTOCHROME P450 4A ISOFORMS
细胞色素 P450 4A 异构体的功能和调节
- 批准号:
6796314 - 财政年份:2003
- 资助金额:
$ 32.73万 - 项目类别:
FUNCTION AND REGULATION OF CYTOCHROME P450 4A ISOFORMS
细胞色素 P450 4A 异构体的功能和调节
- 批准号:
6653343 - 财政年份:2002
- 资助金额:
$ 32.73万 - 项目类别:
FUNCTION AND REGULATION OF CYTOCHROME P450 4A ISOFORMS
细胞色素 P450 4A 异构体的功能和调节
- 批准号:
6578854 - 财政年份:2001
- 资助金额:
$ 32.73万 - 项目类别:
FUNCTION AND REGULATION OF CYTOCHROME P450 4A ISOFORMS
细胞色素 P450 4A 异构体的功能和调节
- 批准号:
6500478 - 财政年份:2001
- 资助金额:
$ 32.73万 - 项目类别:
FUNCTION AND REGULATION OF CYTOCHROME P450 4A ISOFORMS
细胞色素 P450 4A 异构体的功能和调节
- 批准号:
6353524 - 财政年份:2000
- 资助金额:
$ 32.73万 - 项目类别:
ARACHIDONATE OMEGA 1 HYDROXYLATION IN HYPERTENSION
高血压中的花生四烯酸 Omega 1 羟基化
- 批准号:
6202241 - 财政年份:1999
- 资助金额:
$ 32.73万 - 项目类别:
ARACHIDONATE OMEGA 1 HYDROXYLATION IN HYPERTENSION
高血压中的花生四烯酸 Omega 1 羟基化
- 批准号:
6109762 - 财政年份:1998
- 资助金额:
$ 32.73万 - 项目类别:
相似海外基金
Regulation and Consequences of Cytochrome P450 2E1
细胞色素 P450 2E1 的调节和后果
- 批准号:
10713697 - 财政年份:2023
- 资助金额:
$ 32.73万 - 项目类别:
Defining Structural and Functional Differences Between Cytochrome P450 11B1 and 11B2 Interactions with Redox Partner Adrenodoxin for Developing Cushing’s Disease and Primary Aldosteronism Treatments
定义细胞色素 P450 11B1 和 11B2 与氧化还原伙伴肾上腺素的相互作用在库欣病和原发性醛固酮增多症治疗中的结构和功能差异
- 批准号:
10536786 - 财政年份:2022
- 资助金额:
$ 32.73万 - 项目类别:
Role of cytochrome P450 enzymes in pancreatic islets and diabetes pathophysiology
细胞色素 P450 酶在胰岛和糖尿病病理生理学中的作用
- 批准号:
572785-2022 - 财政年份:2022
- 资助金额:
$ 32.73万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Master's
Inter-Enzyme Crosstalk in the Cytochrome P450 Ensemble: Implications for the Effects of Alcohol on Drug Metabolism and Alcohol-Drug Interactions
细胞色素 P450 整体中的酶间串扰:酒精对药物代谢和酒精-药物相互作用影响的影响
- 批准号:
10704053 - 财政年份:2022
- 资助金额:
$ 32.73万 - 项目类别:
Structure-Function of Insect Odorant-Binding Proteins and a Bacterial Cytochrome P450: Discovery of Mechanisms and Applications
昆虫气味结合蛋白和细菌细胞色素 P450 的结构功能:机制的发现和应用
- 批准号:
RGPIN-2020-05297 - 财政年份:2022
- 资助金额:
$ 32.73万 - 项目类别:
Discovery Grants Program - Individual
LEAPS-MPS: Determining All the Contributions of Adrenodoxin to Cytochrome P450 Catalysis
LEAPS-MPS:确定肾上腺氧还蛋白对细胞色素 P450 催化的所有贡献
- 批准号:
2213207 - 财政年份:2022
- 资助金额:
$ 32.73万 - 项目类别:
Standard Grant
Inter-Enzyme Crosstalk in the Cytochrome P450 Ensemble: Implications for the Effects of Alcohol on Drug Metabolism and Alcohol-Drug Interactions
细胞色素 P450 整体中的酶间串扰:酒精对药物代谢和酒精-药物相互作用影响的影响
- 批准号:
10445619 - 财政年份:2022
- 资助金额:
$ 32.73万 - 项目类别:
Role of cytochrome P450 enzymes in pathogenesis of cardiac hypertrophy in different sexes
细胞色素P450酶在不同性别心肌肥厚发病机制中的作用
- 批准号:
475633 - 财政年份:2022
- 资助金额:
$ 32.73万 - 项目类别:
Studentship Programs
Defining Structural and Functional Differences Between Cytochrome P450 11B1 and 11B2 Interactions with Redox Partner Adrenodoxin for Developing Cushing’s Disease and Primary Aldosteronism Treatments
定义细胞色素 P450 11B1 和 11B2 与氧化还原伙伴肾上腺素的相互作用在库欣病和原发性醛固酮增多症治疗中的结构和功能差异
- 批准号:
10685280 - 财政年份:2022
- 资助金额:
$ 32.73万 - 项目类别:
Application of physiologically-based pharmacokinetic (PBPK) models to assess food effects on oral absorption and evaluate metabolic consequences of cytochrome P450 induction
应用基于生理的药代动力学 (PBPK) 模型评估食物对口服吸收的影响并评估细胞色素 P450 诱导的代谢后果
- 批准号:
570107-2022 - 财政年份:2022
- 资助金额:
$ 32.73万 - 项目类别:
Postgraduate Scholarships - Doctoral